Showing results (21-30 of 99) with videos related to
Sort By:
Pageof 10
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2005
Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapyBenjamin Boesler, David Czock, Frieder Keller, et al.Leukemia & Lymphoma|September 17, 2004
Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization studyJuergen Thiele, Hans Michael Kvasnicka, Eva Varus, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone sizeMartin Grünewald, Annelie Siegemund, Anja Grünewald, et al.Annals of Hematology|November 20, 2020
Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasmsKarlo Huenerbein, Parvis Sadjadian, Tatjana Becker, et al.Clinical Drug Investigation|November 28, 2012
Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an interim analysis of the EXELS studyJean-Jacques Kiladjian, Carlos Besses, Martin Griesshammer, et al.Journal of Cancer Research and Clinical Oncology|November 3, 2020
Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safetyLukas Schrickel, Florian H Heidel, Parvis Sadjadian, et al.Journal of Cancer Research and Clinical Oncology|November 28, 2021
Subtyping non-small cell lung cancer by histology-guided spatial metabolomicsJudith Martha Neumann, Hinrich Freitag, Jasmin Saskia Hartmann, et al.Blood|January 17, 2004
Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapyHans Michael Kvasnicka, Juergen Thiele, Peter Staib, et al.Annals of Hematology|March 26, 2013
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II studyKirsten Merx, Alice Fabarius, Philipp Erben, et al.Haematologica|December 17, 2013
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety studyLuigi Gugliotta, Carlos Besses, Martin Griesshammer, et al.Pageof 10